Stay updated on Pembrolizumab Combo With Local Ablation in HCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page.

Latest updates to the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page
- Check5 days agoChange DetectedThe revision tag changed from v3.6.4 to v3.6.5. This indicates a minor update or patch to the page's template/metadata rather than changes to the study content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a new version of the page. This update appears to reflect backend or formatting adjustments rather than substantive changes to the study information.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, reflecting a small administrative update to the page. It does not indicate changes to the study details or outcomes.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a software version bump; this likely reflects minor fixes or enhancements without altering the study details displayed on the page.SummaryDifference0.1%

- Check62 days agoChange DetectedNew sections for user guidance (How to Read a Study Record, Common Questions, How to Join a Study) and a No longer looking for participants notice were added, while the Intervention/Treatment header was standardized. The sponsor designation was updated to Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest and the page revision shows v3.6.0 (replacing v3.5.5).SummaryDifference0.5%

- Check69 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5, signaling a new revision of the page content; this appears to be an internal version update.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Combo With Local Ablation in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo With Local Ablation in HCC Clinical Trial page.